Ovarian Granulosa Cell Tumor

Oncology·MeSH: Ovarian Neoplasms

7 drugs in development·3 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
New Formulation of Niraparib and Abiraterone Acetate	Myovant Sciences Ltd. (MYOV)

Phase 2(4)

Drug	Company
Abiraterone Acetate	Myovant Sciences Ltd. (MYOV)
Darolutamide	ENANTA PHARMACEUTICALS INC (ENTA)
Leuprolide Acetate	Janux Therapeutics, Inc. (JANX)
Leuprolide Acetate	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 4(2)

Drug	Company
Darolutamide	Myovant Sciences Ltd. (MYOV)
Leuprolide Acetate	Myovant Sciences Ltd. (MYOV)

BioSniper tracks 7 drugs in development for Ovarian Granulosa Cell Tumor across 3 companies.

There are 1 clinical trial targeting Ovarian Granulosa Cell Tumor tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.